• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素包膜在预防心脏植入式电子设备感染中的作用:对14859例手术的荟萃分析

Role of antibiotic envelopes in preventing cardiac implantable electronic device infection: A meta-analysis of 14 859 procedures.

作者信息

Kumar Ashish, Doshi Rajkumar, Shariff Mariam

机构信息

Department of Critical Care Medicine St John's Medical College Hospital Bangalore India.

Department of Internal Medicine University of Nevada Reno School of Medicine Reno NV USA.

出版信息

J Arrhythm. 2019 Nov 18;36(1):176-179. doi: 10.1002/joa3.12262. eCollection 2020 Feb.

DOI:10.1002/joa3.12262
PMID:32071638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7011793/
Abstract

INTRODUCTION

We conducted an updated meta-analysis assessing the role of antibiotic envelopes in preventing Cardiac implantable electronic devices (CIED)-related infections as compared to standard infection prevention strategies.

METHODS

A systematic search was conducted on Medline/PubMed and EMBASE/Ovid database. We used Mantel-Haenszel method with fixed-effect model to compute risk ratio (RR) with 95% confidence interval (CI). We also performed subgroup and trial sequential analysis on the data.

RESULTS

Antibiotic envelope reduced the risk of both all infections [RR: 0.41, CI: 0.31-0.54,  < .05,  = 75%,  < .05] and major infections [RR: 0.48, CI: 0.32-0.70,  < .05,  = 60%,  = .04].

CONCLUSION

Prophylactic use of antibiotic envelopes as an adjuvant therapy to standard infection prevention strategies, helps in reducing the risk of CIED infections.

摘要

引言

我们进行了一项更新的荟萃分析,评估与标准感染预防策略相比,抗生素包膜在预防心脏植入式电子设备(CIED)相关感染中的作用。

方法

对Medline/PubMed和EMBASE/Ovid数据库进行系统检索。我们使用固定效应模型的Mantel-Haenszel方法计算风险比(RR)及95%置信区间(CI)。我们还对数据进行了亚组分析和试验序贯分析。

结果

抗生素包膜降低了所有感染的风险[RR:0.41,CI:0.31 - 0.54,P <.05,I² = 75%,P <.05]和主要感染的风险[RR:0.48,CI:0.32 - 0.70,P <.05,I² = 60%,P =. .04]。

结论

预防性使用抗生素包膜作为标准感染预防策略的辅助治疗,有助于降低CIED感染的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/7011793/e5eb2820868c/JOA3-36-176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/7011793/e5eb2820868c/JOA3-36-176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f33/7011793/e5eb2820868c/JOA3-36-176-g001.jpg

相似文献

1
Role of antibiotic envelopes in preventing cardiac implantable electronic device infection: A meta-analysis of 14 859 procedures.抗生素包膜在预防心脏植入式电子设备感染中的作用:对14859例手术的荟萃分析
J Arrhythm. 2019 Nov 18;36(1):176-179. doi: 10.1002/joa3.12262. eCollection 2020 Feb.
2
The role of an antibiotic envelope in the prevention of major cardiac implantable electronic device infections: A systematic review and meta-analysis.抗生素包膜在预防主要心脏植入式电子设备感染中的作用:一项系统评价和荟萃分析。
Medicine (Baltimore). 2020 Jun 26;99(26):e20834. doi: 10.1097/MD.0000000000020834.
3
Antibiotic envelope is associated with reduction in cardiac implantable electronic devices infections especially for high-power device-Systematic review and meta-analysis.抗生素包膜与心脏植入式电子设备感染的减少相关,尤其是对于高功率设备——系统评价和荟萃分析。
J Arrhythm. 2019 Nov 29;36(1):166-173. doi: 10.1002/joa3.12270. eCollection 2020 Feb.
4
Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis.使用抗生素信封预防心脏植入式电子设备感染:一项荟萃分析。
J Cardiovasc Electrophysiol. 2018 Apr;29(4):609-615. doi: 10.1111/jce.13436. Epub 2018 Feb 27.
5
Antibiotic-Eluting Envelopes to Prevent Cardiac-Implantable Electronic Device Infection: Past, Present, and Future.抗生素洗脱封套预防心脏植入式电子设备感染:过去、现在与未来
Cureus. 2021 Feb 2;13(2):e13088. doi: 10.7759/cureus.13088.
6
Antibiotic-Eluting Envelopes for the Prevention of Cardiac Implantable Electronic Device Infections: Rationale, Efficacy, and Cost-Effectiveness.用于预防心脏植入式电子设备感染的抗生素洗脱封套:原理、疗效及成本效益
Front Cardiovasc Med. 2022 Mar 28;9:855233. doi: 10.3389/fcvm.2022.855233. eCollection 2022.
7
A meta-analysis of antibacterial envelope use in prevention of cardiovascular implantable electronic device infection.一项关于使用抗菌封套预防心血管植入式电子设备感染的荟萃分析。
Ther Adv Infect Dis. 2017 May;4(3):75-82. doi: 10.1177/2049936117702317. Epub 2017 May 1.
8
Risk profiles and outcomes of patients receiving antibacterial cardiovascular implantable electronic device envelopes: A retrospective analysis.接受抗菌心血管植入式电子设备包膜患者的风险概况和结局:一项回顾性分析。
World J Cardiol. 2022 Mar 26;14(3):177-186. doi: 10.4330/wjc.v14.i3.177.
9
Physician antibiotic hydration preferences for biologic antibacterial envelopes during cardiac implantable device procedures.心脏植入式设备手术期间医生对生物抗菌包膜的抗生素水化偏好。
Front Cardiovasc Med. 2022 Dec 22;9:1006091. doi: 10.3389/fcvm.2022.1006091. eCollection 2022.
10
Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis.心脏植入式电子设备程序引起的血肿的感染后果和抗生素包膜的作用:WRAP-IT 试验分析。
Heart Rhythm. 2021 Dec;18(12):2080-2086. doi: 10.1016/j.hrthm.2021.07.011. Epub 2021 Jul 17.

引用本文的文献

1
Antimicrobial Performance of a Novel Drug-Eluting Bioenvelope.一种新型药物洗脱生物包膜的抗菌性能
Antibiotics (Basel). 2025 Mar 21;14(4):330. doi: 10.3390/antibiotics14040330.
2
Gram-Negative Bacterial Infections in Cardiac Implantable Electronic Devices: Insights from a Retrospective Analysis of Multidrug-Resistant and Non-Multidrug-Resistant Isolates.心脏植入式电子设备中的革兰氏阴性菌感染:对多重耐药和非多重耐药分离株的回顾性分析见解
Pathogens. 2025 Feb 22;14(3):215. doi: 10.3390/pathogens14030215.
3
The BLISTER Score: A Novel, Externally Validated Tool for Predicting Cardiac Implantable Electronic Device Infections, and Its Cost-Utility Implications for Antimicrobial Envelope Use.

本文引用的文献

1
Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.抗菌包膜预防心脏植入式电子设备感染。
N Engl J Med. 2019 May 16;380(20):1895-1905. doi: 10.1056/NEJMoa1901111. Epub 2019 Mar 17.
2
Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.抗菌包膜与植入式心脏复律除颤器和心脏再同步治疗装置更换后的低感染率相关:Citadel 和 Centurion 研究的结果。
JACC Clin Electrophysiol. 2017 Oct;3(10):1158-1167. doi: 10.1016/j.jacep.2017.02.016. Epub 2017 May 31.
3
BLISTER 评分:一种预测心脏植入式电子设备感染的新型、外部验证工具,以及其对使用抗菌套囊的成本-效用影响。
Circ Arrhythm Electrophysiol. 2024 Mar;17(3):e012446. doi: 10.1161/CIRCEP.123.012446. Epub 2024 Jan 22.
4
Physician antibiotic hydration preferences for biologic antibacterial envelopes during cardiac implantable device procedures.心脏植入式设备手术期间医生对生物抗菌包膜的抗生素水化偏好。
Front Cardiovasc Med. 2022 Dec 22;9:1006091. doi: 10.3389/fcvm.2022.1006091. eCollection 2022.
5
Anti-biofilm activity of antibiotic-loaded Hylomate®.负载抗生素的Hylomate®的抗生物膜活性。
Int J Cardiol Heart Vasc. 2021 Jun 8;34:100801. doi: 10.1016/j.ijcha.2021.100801. eCollection 2021 Jun.
6
Prevention of cardiac implantable electronic device infections: guidelines and conventional prophylaxis.心脏植入式电子设备感染的预防:指南与传统预防措施
Europace. 2021 May 25;23(Suppl 4):iv11-9. doi: 10.1093/europace/euab071.
7
Reply "Role of antibiotic envelopes in preventing cardiac implantable electronic device infection: A meta-analysis of 14 859 procedures".回复《抗生素包膜在预防心脏植入式电子设备感染中的作用:对14859例手术的荟萃分析》
J Arrhythm. 2020 Mar 18;36(3):544-545. doi: 10.1002/joa3.12327. eCollection 2020 Jun.
8
Role of antibiotic envelopes in preventing cardiac implantable electronic device infection: A meta-analysis of 14 859 procedures.抗生素包膜在预防心脏植入式电子设备感染中的作用:对14859例手术的荟萃分析
J Arrhythm. 2020 Jan 16;36(2):377. doi: 10.1002/joa3.12302. eCollection 2020 Apr.
Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection.
TYRX可吸收抗菌包膜预防心血管植入式电子设备感染的成本效益
J Med Econ. 2018 Mar;21(3):294-300. doi: 10.1080/13696998.2017.1409227. Epub 2018 Jan 3.
4
A meta-analysis of antibacterial envelope use in prevention of cardiovascular implantable electronic device infection.一项关于使用抗菌封套预防心血管植入式电子设备感染的荟萃分析。
Ther Adv Infect Dis. 2017 May;4(3):75-82. doi: 10.1177/2049936117702317. Epub 2017 May 1.
5
Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes.使用和不使用抗菌封套的心血管植入式电子设备感染的回顾性比较分析
J Hosp Infect. 2017 Mar;95(3):286-291. doi: 10.1016/j.jhin.2016.12.014. Epub 2016 Dec 23.
6
Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects.一种生物可吸收抗菌封套预防高危受试者心脏植入式电子设备感染的疗效
J Cardiovasc Electrophysiol. 2015 Oct;26(10):1111-6. doi: 10.1111/jce.12768. Epub 2015 Sep 6.
7
Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.与使用抗菌封套作为心脏植入式电子设备植入护理标准相关的健康和经济结果
J Cardiovasc Electrophysiol. 2015 Jul;26(7):783-9. doi: 10.1111/jce.12684. Epub 2015 May 25.
8
Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.心脏植入式电子设备感染:发生率、风险因素以及 AigisRx 抗菌封套的效果。
Heart Rhythm. 2014 Apr;11(4):595-601. doi: 10.1016/j.hrthm.2013.12.013. Epub 2013 Dec 10.
9
Predictors of mortality in patients with cardiovascular implantable electronic device infections.心血管植入式电子设备感染患者的死亡率预测因素。
Am J Cardiol. 2013 Mar 15;111(6):874-9. doi: 10.1016/j.amjcard.2012.11.052. Epub 2012 Dec 29.
10
16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.1993 年至 2008 年美国起搏器和植入式心脏复律除颤器感染负担的 16 年趋势。
J Am Coll Cardiol. 2011 Aug 30;58(10):1001-6. doi: 10.1016/j.jacc.2011.04.033.